Home › Funds › Millennium Management › CTMX
Millennium Management position in CTMX
CYTOMX THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)1.69M sh
Reported value held$6.32M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 936.85K | $4.77M | New |
| Q4 2021 | 1.27M | $5.49M | Add |
| Q1 2022 | 2.25M | $6.00M | Add |
| Q2 2022 | 1.44M | $2.64M | Reduce |
| Q3 2022 | 532.51K | $772.00K | Reduce |
| Q4 2022 | 1.72M | $2.75K | Add |
| Q1 2023 | 961.04K | $1.45K | Reduce |
| Q2 2023 | 649.30K | $1.12M | Reduce |
| Q3 2023 | 698.91K | $901.59K | Add |
| Q4 2023 | 794.05K | $1.23M | Add |
| Q1 2024 | 671.63K | $1.46M | Reduce |
| Q2 2024 | 1.85M | $2.25M | Add |
| Q3 2024 | 2.56M | $3.02M | Add |
| Q4 2024 | 3.22M | $3.32M | Add |
| Q1 2025 | 2.83M | $1.80M | Reduce |
| Q2 2025 | 233.34K | $529.68K | Reduce |
| Q3 2025 | 1.39M | $4.42M | Add |
| Q4 2025 | 289.65K | $1.23M | Reduce |
| Q1 2026 | 3.66M | $17.20M | Add |
| Q2 2026 | 1.69M | $6.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTMX
- Fidelity Management & Research (FMR) 32.71M sh · $122.68M · Q2 2026
- BlackRock Inc 17.56M sh · $65.85M · Q2 2026
- Bank of America Corp 15.08M sh · $56.56M · Q2 2026
- Vanguard Group 8.48M sh · $36.11M · Q4 2025
- Point72 Asset Management 7.81M sh · $29.29M · Q2 2026
- Wellington Management Group 5.17M sh · $19.38M · Q2 2026
- Geode Capital Management 4.68M sh · $17.55M · Q2 2026
- Two Sigma Investments 4.13M sh · $15.50M · Q2 2026
- UBS Group AG 3.47M sh · $13.01M · Q2 2026
- Citadel Advisors 3.33M sh · $12.49M · Q2 2026
- Marshall Wace 3.02M sh · $11.34M · Q2 2026
- Goldman Sachs Group 2.00M sh · $7.51M · Q2 2026